healthy women
Conditions
Interventions
None listed
Sponsors
TES Holdings CO., Ltd.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1) Individuals who have provided written consent for participation in the study. 2) Japanese premenopausal women between 20 and under 40 years of age at the time of consent 3) Individuals with a BMI less than 25 4) Individuals who can come to the clinic on the designated examination date and undergo the examination.
Exclusion criteria
Exclusion criteria: 1) Individuals with soy allergy symptoms 2) Individuals with metal allergy symptoms 3) Individuals who wearing a pacemaker or other medical electrical device 4) Individuals who are pregnant, lactating, or wish to become pregnant during the study period 5) Individuals who have diastolic blood pressure lower than 40 mmHg or systolic blood pressure of higher than 180 mmHg 6) Individuals with any chronic disease and receiving drug treatment. 7) Individuals who have had uterus or bilateral ovaries removed 8) Individuals participating in other clinical trials 9) Individuals whoes test results are positive for syphilis serology, HIV antigen antibody, HVC antibody, or HBs antigen. 10) Individuals who are judged by the principal investigator/ study director to be inappropriate to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vascular function, physical/mental symptoms | — |
Countries
Japan
Contacts
Public ContactRyoma Shimizu
TES Holdings CO., Ltd. Administrative Department of Clinical Trials
Outcome results
None listed